SAN DIEGO, April 27, 2010 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq:AMLN - News) will be presenting at the Deutsche Bank 35th Annual Healthcare Conference in Boston on Tuesday, May 4, 2010 at 10:40 a.m. ET / 7:40 a.m. PT. Daniel M. Bradbury, president and chief executive officer of Amylin Pharmaceuticals, will provide a corporate overview.
